Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model

• Chhanda Bose,

  Roles Data curation, Methodology

  Affiliation University of Arkansas for Medical Sciences, Department of Geriatrics, Little Rock, Arkansas, United States of America

  ⨯
• Sanjay Awasthi,

  Roles Writing – review & editing

  Affiliation Texas Tech Health Sciences Center, Division of Hematology & Oncology, Department of Internal Medicine, Lubbock, Texas, United States of America

  ⨯
• Rajendra Sharma,

  Roles Writing – review & editing

  Affiliation University of Arkansas for Medical Sciences, Department of Pharmacology and Toxicology, Little Rock, Arkansas, United States of America

  ⨯
• Helen Beneš,

  Roles Validation

  Affiliation University of Arkansas for Medical Sciences, Department of Neurobiology and Developmental Sciences, Little Rock, Arkansas, United States of America

  ⨯
• Martin Hauer-Jensen,

  Roles Conceptualization, Writing – review & editing

  Affiliation University of Arkansas for Medical Sciences, Division of Radiation Health, Little Rock, Arkansas, United States of America

  ⨯
• Marjan Boerma,

  Roles Formal analysis, Writing – review & editing

  Affiliation University of Arkansas for Medical Sciences, Division of Radiation Health, Little Rock, Arkansas, United States of America

  ⨯
• Sharda P. Singh

  Roles Conceptualization, Funding acquisition, Methodology, Software, Supervision, Visualization, Writing – original draft

  * E-mail: sharda.singh@ttuhsc.edu

  Affiliations Texas Tech Health Sciences Center, Division of Hematology & Oncology, Department of Internal Medicine, Lubbock, Texas, United States of America, University of Arkansas for Medical Sciences, Department of Pharmacology and Toxicology, Little Rock, Arkansas, United States of America, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, United States of America

  http://orcid.org/0000-0003-4361-4558

  ⨯